您好,欢迎访问三七文档
Slide1PresentedByThierryConroyatTBDBackground:stageII/IIIrectalcancer(T3-4,N0orN+)br/PresentedByThierryConroyatTBDSlide3PresentedByThierryConroyatTBDKeyInclusionCriteriaPresentedByThierryConroyatTBDKeyExclusionCriteriaPresentedByThierryConroyatTBDEndpointsPresentedByThierryConroyatTBDStatisticalconsiderationsPresentedByThierryConroyatTBDRecruitmentandanalysisPresentedByThierryConroyatTBDFlowchartPresentedByThierryConroyatTBDPatientsbaselinecharacteristicsPresentedByThierryConroyatTBDBaselinecharacteristicsoftumorsPresentedByThierryConroyatTBDSlide12PresentedByThierryConroyatTBDChemoradiotherapycomplianceandsafetyPresentedByThierryConroyatTBDSlide14PresentedByThierryConroyatTBDSlide15PresentedByThierryConroyatTBDSlide16PresentedByThierryConroyatTBDSlide17PresentedByThierryConroyatTBDSlide18PresentedByThierryConroyatTBDDisease-FreeSurvivalPresentedByThierryConroyatTBDPrognosticfactorsforDFSPresentedByThierryConroyatTBDSlide21PresentedByThierryConroyatTBDSlide22PresentedByThierryConroyatTBDSlide23PresentedByThierryConroyatTBDConclusionsPresentedByThierryConroyatTBDPresentedByThierryConroyatTBDAcknowledgementsPresentedByThierryConroyatTBD
本文标题:UNICANCER-PRODIGE-23-trial-185485-slide-ppt
链接地址:https://www.777doc.com/doc-7115970 .html